ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $266,024 (100.0% shares, 0.0% debt)

Holdings (9)

BEAM BEAM THERAPEUTICS INC. 47.9%

Value ($000) $127,530 Shares 5,443,039 Est. Cost $24.56 Unrealized 0.0%

RAPP RAPPORT THERAPEUTICS, INC. 32.6%

Value ($000) $86,730 Shares 3,728,738 Est. Cost $23.15 Unrealized 0.0%

ERAS ERASCA, INC. 9.8%

Value ($000) $26,091 Shares 11,055,554 Est. Cost $17.12 Unrealized -87.4%

— VERVE THERAPEUTICS, INC. 3.7%

Value ($000) $9,803 Shares 2,008,809 Est. Cost $36.87 Unrealized —

GOSS GOSSAMER BIO, INC. 2.7%

Value ($000) $7,258 Shares 8,055,916 Est. Cost $1.15 Unrealized -35.1%

QTTB Q32 BIO INC. 2.2%

Value ($000) $5,753 Shares 320,482 Est. Cost $13.78 Unrealized +73.6%

— UNITY BIOTECHNOLOGY, INC. 0.5%

Value ($000) $1,357 Shares 1,004,817 Est. Cost $0.40 Unrealized —

— SINGULAR GENOMICS SYSTEMS, INC. 0.4%

Value ($000) $1,070 Shares 126,630 Est. Cost $8.45 Unrealized —

— CERO THERAPEUTICS HOLDINGS, INC. 0.2%

Value ($000) $432 Shares 1,444,296 Est. Cost $3.07 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BEAM	BEAM THERAPEUTICS INC.	5,443,039	$127,530	47.9%	$24.56	0.0%	COM	07373V105
RAPP	RAPPORT THERAPEUTICS, INC.	3,728,738	$86,730	32.6%	$23.15	0.0%	COM	75383L102
ERAS	ERASCA, INC.	11,055,554	$26,091	9.8%	$17.12	-87.4%	COM	29479A108
—	VERVE THERAPEUTICS, INC.	2,008,809	$9,803	3.7%	$36.87	—	COM	92539P101
GOSS	GOSSAMER BIO, INC.	8,055,916	$7,258	2.7%	$1.15	-35.1%	COM	38341P102
QTTB	Q32 BIO INC.	320,482	$5,753	2.2%	$13.78	+73.6%	COM	746964105
—	UNITY BIOTECHNOLOGY, INC.	1,004,817	$1,357	0.5%	$0.40	—	COM NEW	91381U200
—	SINGULAR GENOMICS SYSTEMS, INC.	126,630	$1,070	0.4%	$8.45	—	COM NEW	82933R308
—	CERO THERAPEUTICS HOLDINGS, INC.	1,444,296	$432	0.2%	$3.07	—	CLASS A COM	71902K105